These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2924381)

  • 1. Pharmacokinetics of a new anticancer drug, navelbine, in patients. Comparative study of radioimmunologic and radioactive determination methods.
    Boré P; Rahmani R; van Cantfort J; Focan C; Cano JP
    Cancer Chemother Pharmacol; 1989; 23(4):247-51. PubMed ID: 2924381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of [3H]navelbine in patients: comparative pharmacokinetics using radioactive and radioimmunologic determination methods.
    Rahmani R; Zhou XJ; Boré P; Van Cantfort J; Focan C; Cano JP
    Anticancer Drugs; 1991 Aug; 2(4):405-10. PubMed ID: 1797198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.
    van Tellingen O; Kuijpers AV; Beijnen JH; Nooijen WJ; Bult A
    Invest New Drugs; 1993; 11(2-3):141-50. PubMed ID: 8262726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.
    Jehl F; Quoix E; Leveque D; Pauli G; Breillout F; Krikorian A; Monteil H
    Cancer Res; 1991 Apr; 51(8):2073-6. PubMed ID: 1849042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary elimination and pharmacokinetics of vinorelbine in micropigs.
    Levêque D; Merle-Melet M; Bresler L; Didelot JP; Aymard JP; Wihlm J; Jehl F
    Cancer Chemother Pharmacol; 1993; 32(6):487-90. PubMed ID: 8258199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical pharmacokinetics of vinorelbine (Navelbine).
    Wargin WA; Lucas VS
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of vinorelbine, a new semi-synthetic vinca alkaloid, determined by high-performance liquid chromatography.
    Levêque D; Jehl F; Quoix E; Monteil H
    Xenobiotica; 1993 Nov; 23(11):1325-33. PubMed ID: 8310715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancer.
    Levêque D; Quoix E; Dumont P; Massard G; Hentz JG; Charloux A; Jehl F
    Cancer Chemother Pharmacol; 1993; 33(2):176-8. PubMed ID: 8261579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice.
    Tsuruo T; Inaba M; Tashiro T; Yamori T; Ohnishi Y; Ashizawa T; Sakai T; Kobayashi S; Gomi K
    Anticancer Drugs; 1994 Dec; 5(6):634-40. PubMed ID: 7888700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical pharmacokinetics of vinca alkaloids].
    Rahmani R; Samak R; Bore P; Cano JP
    Bull Cancer; 1988; 75(2):195-200. PubMed ID: 3359064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of vinorelbine (Navelbine) in tumour cells by high-performance liquid chromatography.
    Debal V; Morjani H; Millot JM; Angiboust JF; Gourdier B; Manfait M
    J Chromatogr; 1992 Oct; 581(1):93-9. PubMed ID: 1430011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of navelbine after oral administration in the dog and the monkey.
    Zhou XJ; Landi H; Breillout F; Rahmani R
    Anticancer Drugs; 1993 Aug; 4(4):511-5. PubMed ID: 8400355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).
    Rahmani R; Bruno R; Iliadis A; Favre R; Just S; Barbet J; Cano JP
    Cancer Res; 1987 Nov; 47(21):5796-9. PubMed ID: 3664483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance liquid chromatographic determination of navelbine in MO4 mouse fibrosarcoma cells and biological fluids.
    Van Belle SJ; De Smet M; Monsaert C; Geerts F; Storme GA; Massart DL
    J Chromatogr; 1992 May; 576(2):351-7. PubMed ID: 1400725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of navelbine after oral administration in cancer patients.
    Zhou XJ; Boré P; Monjanel S; Sahnoun Z; Favre R; Durand A; Rahmani R
    Cancer Chemother Pharmacol; 1991; 29(1):66-70. PubMed ID: 1742851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of vinorelbine.
    Levêque D; Jehl F
    Clin Pharmacokinet; 1996 Sep; 31(3):184-97. PubMed ID: 8877249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
    Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
    Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I pharmacologic study of a new Vinca alkaloid: navelbine.
    Mathé G; Reizenstein P
    Cancer Lett; 1985 Jul; 27(3):285-93. PubMed ID: 4016723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacokinetics of navelbine after oral administration, in vitro metabolism and interindividual variability].
    Sahnoun Z; Zhou XJ; Bore P; Monjanel S; Favre R; Durand A; Rahmani R
    Bull Cancer; 1990; 77(11):1115-21. PubMed ID: 2275987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of vinorelbine in man.
    Marquet P; Lachatre G; Debord J; Eichler B; Bonnaud F; Nicot G
    Eur J Clin Pharmacol; 1992; 42(5):545-7. PubMed ID: 1607002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.